Robotic vs. Open NSM for Early Stage Breast Cancer
Launched by INTUITIVE SURGICAL · Jan 30, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical methods for treating early-stage breast cancer in women: a robotic technique using the da Vinci SP Surgical System and a traditional open surgery called Nipple Sparing Mastectomy (NSM). The goal is to see which method is safer and more effective for women undergoing this type of surgery, which allows for the removal of breast tissue while preserving the nipple and can be followed by immediate breast reconstruction.
To be eligible for this trial, participants need to be women aged 21 or older with a body mass index (BMI) of less than 30 who are suitable candidates for the NSM procedure. They should have early-stage breast cancer and certain breast characteristics, such as a cup size of C or smaller. Unfortunately, women who have had previous breast surgery, certain types of breast cancer, or other specific health issues won't be able to participate. If you join the study, you can expect to undergo one of the two surgical procedures and will be monitored for safety and effectiveness afterward. This trial is currently recruiting participants, so there's an opportunity to contribute to important research while receiving care for breast cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female age 21 or older
- • BMI \< 30
- • Candidate for an NSM procedure with immediate reconstruction
- • Diagnosis of early stage brest cancer
- • Breast ptosis ≤ Grade 2.
- • Cup size ≤ C.
- Exclusion Criteria:
- • Previous breast surgery
- • Diagnosis of metastatic breast cancer
- • Prior radiation treatment to the chest
- • Current smokers
- • Contraindication for general anesthesia or surgery.
- • Known bleeding or clotting disorder.
- • Pregnant or suspected to be pregnant, or actively breastfeeding
About Intuitive Surgical
Intuitive Surgical is a leading innovator in robotic-assisted minimally invasive surgery, dedicated to enhancing surgical outcomes through advanced technology. Renowned for its da Vinci Surgical System, the company develops cutting-edge surgical platforms that empower healthcare professionals to perform complex procedures with precision and control. Committed to clinical excellence and patient safety, Intuitive Surgical actively sponsors clinical trials to advance the understanding and application of robotic surgery across various specialties, ultimately aiming to improve patient care and surgical results worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Duarte, California, United States
Durham, North Carolina, United States
Houston, Texas, United States
Jacksonville, Florida, United States
Philadelphia, Pennsylvania, United States
St. Louis, Missouri, United States
Evanston, Illinois, United States
Nashville, Tennessee, United States
Rochester, Minnesota, United States
Saint Louis, Missouri, United States
Atlanta, Georgia, United States
Lake Success, New York, United States
Los Angeles, California, United States
Detroit, Michigan, United States
Milwaukee, Wisconsin, United States
Irvine, California, United States
Evanston, Illinois, United States
Patients applied
Trial Officials
Madhu Gorrepati
Study Director
Intuitive
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials